Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve.
J Immunother Cancer
; 9(2)2021 02.
Article
in En
| MEDLINE
| ID: mdl-33602696
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Colorectal Neoplasms
/
Vaccines, DNA
/
Triple Negative Breast Neoplasms
/
Antineoplastic Agents, Immunological
/
Docetaxel
/
Immune Checkpoint Inhibitors
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: